096530.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 23:16):

Stats
Today's Volume	35 248.00
Average Volume	561 264
Market Cap	1 006.06B
EPS	KRW0 ( 2024-02-15 )
Next earnings date	( KRW0 ) 2024-05-10
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW39.58 (0.18%)

Volume Correlation

Long: 0.02 (neutral)

Short: -0.38 (neutral)

Signal:(47.092) Neutral

Seegene, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Seegene, Inc. Correlation - Currency/Commodity

0.04
( neutral )

0.03
( neutral )

0.02
( neutral )

0.12
( neutral )

-0.13
( neutral )

Seegene, Inc. Financials

Annual	2023
Revenue:	KRW367.38B
Gross Profit:	KRW180.07B (49.02 %)
EPS:	KRW14.19

Q4	2023
Revenue:	KRW100.51B
Gross Profit:	KRW55.10B (54.82 %)
EPS:	KRW126.69

Q3	2023
Revenue:	KRW91.89B
Gross Profit:	KRW45.30B (49.30 %)
EPS:	KRW-100.58

Q2	2023
Revenue:	KRW84.93B
Gross Profit:	KRW39.46B (46.47 %)
EPS:	KRW-53.89

Financial Reports:

No articles found.

Seegene, Inc.

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of six SNPs in factor II, factor V, and MTHFR genes; BRAF mutation characteristic for papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy, H&E slides, and paraffin-embedded tissues; Apolipoprotein E genotypes; and BCR/ABL fusion gene from blood and whole bone marrow. In addition, it offers PCR machines; vial cap management systems; nucleic acid extraction systems; automated liquid handling workstations from nucleic acid extraction to PCR setup; and real-time PCR detection systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.